Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Jan 29, 2018 8:03am
130 Views
Post# 27452629

RE:The FDA will approve safe use of PMX (Factfinder)

RE:The FDA will approve safe use of PMX (Factfinder)
Newnerd, Be careful you don't invest more than you can afford to lose!! I believe that they will get approval for PMX but am still wondering why in 13 years (actually 15) Spectral has not been able to SELL their EAA to hospitals. I hope they are better at selling/joint venturing when PMX is approved. There is now a simple blood test to tell if sepsis present but I don't think that it can tell how much. It would be ?simpler/cheaper? to give that test so they don't send home people who might be considered having the flu? Maybe if sepsis shows its presence, they would administer the EAA??
Bullboard Posts